SEC Filing Analysis: Werewolf Therapeutics, Inc. (HOWL)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director conducted a series of small, pre-planned stock sales totaling approximately $52,000, representing a negligible fraction of the company's market cap.
• Market Impact: The transactions are unlikely to have any market impact due to their small size and pre-scheduled nature under a Rule 10b5-1 plan.

Company Information

Field	Value
Company	Werewolf Therapeutics, Inc.
Ticker Symbol	HOWL
CIK	0001785530
Industry	PHARMACEUTICAL PREPARATIONS [2834]

Insider Information

Field	Value
Name	EVNIN LUKE
CIK	0001134657
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-12-15 to 2025-12-17
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	48,171 (aggregate)
Price Per Share	~$1.08 (weighted average)
Total Value	$51,951
Shares Owned After	2,841,957
Ownership Type	Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$51,951
% of Market Cap	0.13%
Shares Transacted	48,171
% of Shares Outstanding	Not Available
Post-Transaction Ownership	2,841,957 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The total sale of ~$52k is a minor event for a company with a $40 million market capitalization. The transaction value constitutes only 0.13% of the company's total market value, falling well below the threshold for moderate significance.
• Ownership Concentration: The insider continues to hold a substantial position of 2,841,957 shares indirectly through various funds. The sale represents a very small portion of their total holdings.
• Transaction Significance: The significance is low. The value is small in both absolute terms and relative to the market cap. The pre-scheduled nature of the sale further diminishes its importance as a market signal.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sales were executed under a Rule 10b5-1 trading plan established months prior. Such plans are typically used for personal financial management and do not reflect an insider's immediate outlook on the company's performance.

Volume & Sentiment

• Expected Volume Impact: Negligible. The number of shares sold is too small to materially affect trading volume.
• Sentiment Indicator: Neutral. The market generally disregards small, pre-planned sales.

Additional Context

Transaction Notes

• Special Circumstances: As stated in Footnote 1, all transactions were "effected pursuant to a plan established pursuant to Rule 10b5-1 dated September 24, 2025."
• Ownership Structure: The shares are held indirectly by various MPM-affiliated funds, of which the reporting person is a managing member or director, as detailed in the filing's footnotes.